Gout and the Metabolic Syndrome 9. Korea National Statistical Office. Population projections for Korea: 2000-2050. 2001: 63. 10. Lee WY, Park JS, Noh SY, Rhee EJ, Kim SW, Zimmet PZ. Preva- lence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract 2004; 65: 143-9. 11. Kim MH, Kim MK, Choi BY, Shin YJ. Prevalence of the metabolic syndrome and its association with cardiovascular diseases in Korea. J Korean Med Sci 2004; 19: 195-201. 12. Steering Committee of the WHO Western Pacific Region, IASO & IOTF. The Asia-Pacific perspective: Redefining obesity and its treat- ment. Australia, 2000. 13. Jeon CH, Kim HJ, Kim EH, Ahn JK, Koh JH, Cha HS, Koh EM. Clinical manifestations of gout in Korea. Korean J Med 2002; 62: 648-56. 14. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607. 15. Vazquez-Mellado J, Garcia-Garcia C, Guzman-Vazquez S, Medrano G, Ornelas M, Alcocer L, Marquez A, Burgos-Vargas R. Ischemic heart disease and metabolic syndrome in gout. J Clin Rheumatol 2004; 10: 105-9. 16. Kwon HS, Park YM, Lee HJ, Lee JH, Choi YH, Ko SH, Lee JM, Kim SR, Kang SY, Lee WC, Ahn MS, Noh JH, Kang JM, Kim DS, Yoon KH, Cha BY, Lee KW, Kang SK, Son HY. The prevalence and clinical characteristics of the metabolic syndrome in middle-aged Korean adults. Korean J Med 2005; 68: 359-68. 17. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004; 363: 1277-81. 18. Kiechl S, Willeit J, Poewe W, Egger G, Oberhollenzer F, Muggeo M, Bonora E. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). 1033 BMJ 1996; 313: 1040-4. 19. Goude D, Fagerberg B, Hulthe J. Alcohol consumption, the metabolic syndrome and insulin resistance in 58-year-old clinically healthy men (AIR study). Clin Sci (Lond) 2002; 102: 345-52. 20. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heyms- field SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163: 427-36. 21. Rosell M, De Faire U, Hellenius ML. Low prevalence of the metabolic syndrome in wine drinkers--is it the alcohol beverage or the lifestyle? Eur J Clin Nutr 2003; 57: 227-34. 22. Yoon YS, Oh SW, Baik HW, Park HS, Kim WY. Alcohol consump- tion and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am J Clin Nutr 2004; 80: 217-24. 23. Yoo TW, Sung KC, Kim YC, Hwang ST, Oh SY, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Lee KB, Lhee HY, Ryu SH, Keum DG. The relationship of the hypertension, insulin resis- tance, and metabolic syndrome in the serum uric acid level. Korean Circulation J 2004; 34: 874-82. 24. Tai ES, Emmanuel SC, Chew SK, Tan BY, Tan CE. Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes 1999; 48: 1088-92. 25. Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G. Low HDL- cholesterol: a component of the metabolic syndrome only in the pres- ence of fasting hypertriglyceridemia in type 2 diabetic patients. Dia- betes Metab 2001; 27: 31-5. 26. Bosello O, Zamboni M. Visceral obesity and metabolic syndrome. Obes Rev 2000; 1: 47-56.